Recently, two leading and long-established firms in the expanding AI drug discovery sector revealed an unexpected merger. In an approximate 75-25 agreement, Recursion Bio and Exscientia are set to ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million Skip to main content Tuesday 24 June 2025 . BlueSky ...

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025 GlobeNewswire Apr 23, 2025, 12:34:17 AM ...

A breakdown of this level will see XRP price fall toward the downside target of the prevailing chart pattern at around $1.18, down 41% from current price levels.

2025 NBA playoffs: Conference finals schedule . All times Eastern. Tuesday, May 20 Game 1: Thunder 114, Timberwolves 88 . Wednesday, May 21 Game 1: Pacers 138, Knicks 135 (OT) ...

Berkshire Hathaway operates large insurance, rail transportation, energy, manufacturing, and retail businesses, but its equity portfolio is also a big contributor.

Find annual and quearterly earnings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including earnings per share, earnings forecasts at Nasdaq.com.